Clinical Trials
10 trialsNCT04173533 2024-05-14
AMADEUS
University of Birmingham
Phase 3 Unknown
NCT02338479 2023-02-08
Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
Center for International Blood and Marrow Transplant Research
Unknown
NCT05154474 2022-05-03
SPACE2
Weprom
Unknown
NCT04429191 2021-06-11
JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation
Jasper Therapeutics, Inc.
Phase 1 Unknown
NCT02124174 2021-04-26
Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS
Loyola University
Phase 2 Unknown
NCT04517175 2020-08-18
Could Ki-67 be Used as a Diagnostic or Prognostic Marker in Hemato-oncological Diagnostics?
Maastricht University
Unknown
NCT00003827 2013-12-04
Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00003602 2013-09-20
Combination Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00002926 2010-05-27
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00043134 2010-04-13
Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome
National Cancer Institute (NCI)
Phase 3 Unknown